Noticias HC

Diagnosis of early Alzheimer’s is possible using PET

Beta-amyloid PET imaging is a technology which enables us to diagnose Alzheimer’s when symptoms are still mild, enabling a plan to be established, slowing down deterioration and improving the patient’s quality of life.

 
 

PET y Alzheimer

 
 

Yes, it is possible to diagnose early Alzheimer’s.

This is the main conclusion made in an article published in the Spanish Magazine of Nuclear Medicine and Molecular Imaging (Revista Española de Medicina Nuclear e Imagen Molecular), by some of the most reputable scientists in the field of Alzheimer’s in Spain, a consensus document to raise awareness. The article itself states that there are many healthcare professionals who still believe that no diagnostic tools exist for Alzheimer’s.

 

But there is and Spain is the European leader in its implementation. The technique is known as Positron Emission Tomography (PET) and although its use is essential for the diagnosis and monitoring of tumours, its application in the diagnosis of Alzheimer’s Disease, during the mild deteriorative cognitive phase, has shown to be very effective.

 

Researchers consider PET should only be used in cases of mild cognitive deterioration, in other words, when the first signs of some poor intellectual functioning have been detected at neuropsychological assessment.

 

In clinical practice it makes no sense to test any biomarker in an asymptomatic person, as we can still not state with certainty what this positive marker might signify, explained one of the study’s researchers.

 

However, the first neuroimaging technique they recommend is MRI. It is used to exclude other causes of the symptoms detected, such as a tumour, as well as to assess the degree of cerebral atrophy. MRI is much less sensitive than PET in Alzheimer’s at an initial phase, hence the importance of PET not only for diagnosis but also for differentiation between the different causes of cognitive deterioration.

 
 

HC Marbella provides its patients with the most advanced technology in the field of diagnostic imaging. Both this and the Neurology Unit, with Dr. Jesus Romerao Imbroda, are driving the expansion of diagnostic capacity in the neurological field at HC Marbella International Hospital.

 

Sources: HC Marbella; Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Magazine of Nuclear Medicine and Molecular Imaging).

 

 

October 15, 2019

 

 

 

Read other news

Online appointment and download of test results through My HC.

Tel.: +34 952 908 628

952908898 Oncology
951829978 Diagnosis by imaging
951829947 Gynecology
952908897 Fertility
951829947 Physiotherapy

 

     

     

    I agree to receive e-mails with offers and news about this and other services. *

    YesNo

     

    Responsible: HC Hospitales, S.L. Purpose: Managing the appointment process. Sending you information by newsletter, upon your acceptance. Duration: The data is deleted once the information has been provided to you, unless you contract our services or request us to contact you in the future. With regard to the newsletter, the data is deleted when you unsubscribe from it. Recipients: We do not disclose your data to any other party. Rights: To access, rectify, and delete your data, as well as further rights explained in the additional information webpage: https://clientes.prodat.es/privacidad/MLG/HCMARBELLA

     

    Patient Services

    • 900877454 Call Center
    • 952908898 Oncology
    • 951829978 Diagnosis by imaging
    • 951829947 Gynecology
    • 952908897 Fertility
    • 952908131 Hospital pharmacy

    Subscribe to our newsletter

    • HC Marbella you can access information relevant and topical written by different professionals of our medical health units.
    Subscribe